Advisory groups

Advisory groups give targeted advice on specific issues. 

PHARMAC works with groups of experts to provide advice and recommendations, as needed. The Groups may be set up for varying lengths of time, depending on the type of activity PHARMAC is seeking advice on.

Advisory groups meet as required to discuss issues referred to them by PHARMAC. Minutes of the meetings are published on this website.

4 August 2021: Addition of tocilizumab ad hoc advisory group

Critical Care Advisory Group (ad hoc)

Group formed to advise PHARMAC for the COVID-19 pandemic response.

  • Prof Brian Anderson (Chair) – Anaesthetics
  • Dr Andrew Stapleton – Intensive Care
  • Dr Andrew Brainard - Emergency Medicine Consultant
  • Annie Egan – Intensive Care Pharmacy
  • Dr Bruce King – Internal Medicine
  • Dr Craig Carr – Intensive Care/Clinical Pharmacology
  • Dr Gillian Bishop – Intensive Care
  • Dr Greg Frazer – Respiratory Medicine
  • Dr Matthew Drake – Anaesthetics
  • Dr Seton Henderson – Intensive Care
  • Steve Kirby – Critical Care Nursing 

Interventional Cardiology Advisory Group (ICAG)

  • Dr Scott Harding (Chair) – Interventional Cardiologist
  • Dr Gerry Wilkins – Interventional Cardiologist
  • Dr David Smyth – Structural Interventional Cardiologist
  • Dr Rajesh Nair – Structural Interventional Cardiologist
  • Dr Seif El-Jack – Interventional Cardiologist
  • Dr Mark Webster – Structural Interventionalist
  • Dr Nigel Wilson – Paediatric Cardiologist
  • Dr Barry Kneale – Interventional Cardiologist
  • Mrs Sandi Graham – Cardiology Interventional Nurse 

Remdesivir COVID-19 Advisory Group (Ad hoc)

Group formed to provide clinical advice about using remdesivir to treat COVID-19.

  • Prof Mark Weatherall (Chair, PTAC Member) – Internal Medicine – Geriatric
  • Prof Brian Anderson – Anaesthesia & Intensive Care Medicine Specialist (PTAC Member)
  • Dr Gillian Bishop – Intensive Care
  • Dr Graham Mills – Infectious Disease Physician
  • Prof Stephen Munn – Transplant Surgeon (PTAC Member)
  • Dr Justin Travers – Respiratory Physician

Respiratory Procurement Advisory Group

  • Dr Justin Travers (Chair) – Respiratory Physician
  • Dr Melissa Copland – Pharmacist
  • Dr Andrew Corin – General Practitioner
  • Betty Poot – Respiratory Specialist
  • Ann Wheat – Asthma Nurse Educator/Nurse Manager
  • Ann Nguyen – Hospital Pharmacist
  • Teresa Chalecki – Nurse Manager
  • Dr Phil Weeks – General Practitioner
  • Noelene Rapana – Nurse
  • Joanna Turner – Pharmacist

Tocilizumab Advisory Group (ad hoc)

This advisory group was formed to provide Pharmac with clinical advice on an application received for use of tocilizumab in moderate-severe Covid-19.

  • Prof Mark Weatherall (Chair, PTAC Member) – Internal Medicine – Geriatric
  • Dr Bruce King (PTAC Member) – Specialist Internal Medicine
  • Dr Graham Mills – General and Infectious Disease Physician
  • Dr Marius Rademaker (PTAC Member) – Dermatologist 
  • Prof Stephen Munn (PTAC Member) – Transplant Surgeon
  • Mr Eamon Duffy – Antimicrobial Pharmacist

Wound Care Advisory Group (not currently active)

  • Julie Betts (Chair) – Wound Care Nurse Practitioner
  • Alan Shackleton – Nurse Consultant - Wound Care Service Clinical Lead
  • Amanda Pagan – Wound Care Specialist Nurse
  • Catherine Hammond – Wound Care Clinical Nurse Specialist & Educator
  • Emil Schmidt – Nurse Specialist Wound Care
  • Jonathan Heather – Plastic Surgeon
  • Susie Wendelborn – Specialty Clinical Nurse Wound Care
  • Wendy Mildon – Clinical Nurse Specialist Wound Care